Tomorrow Abbott will publish its past quarters results. Over the current book year the total revenue from the company in Abbott Park will be 39.29 billion USD (consensus estimates). This is quite more than 2020's revenue of 34.61 billion USD.
The analysts expect for 2021 a net profit of 7.78 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 4.36 USD. So the price/earnings-ratio equals 27.25.
For this year the analysts expect a dividend of 1.66 USD per share. Thus the dividend yield equals 1.4 percent. The average dividend yield of the pharmaceutical companies equals a limited 1.39 percent.
Based on the current number of outstanding shares Abbott 's market capitalization 209.4 billion USD. The Abbott stock was the past 12 months quite unstable. Since last July the stock is even 30 percent higher. This year the stock price moved between 92 and 129 dollar.
On Monday the stock closed at 118.81 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.